Case number 1:24-cv-01344
Vanda Pharmaceuticals Inc. v. Apotex Inc. et al > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| May 6, 2025 | 20 | SO ORDERED, re (19 in 1:24-cv-01344-JLH, 164 in 1:23-cv-00153-JLH) Stipulation fand Order to Consolidate Actions. C.A. No. 24-1344-JLH will be consolidated into C.A. No. 23-153-JLH for all purposes and all papers will be filed in C.A. No. 23-153-JLH. (*Reset Scheduling Order Deadlines: Fact Discovery completed by 9/19/2025; Expert Discovery due by 1/9/2026; Interim Status Report due by 7/22/2025; Dispositive and Daubert Motions due by 1/23/2026; Answering Brief due 2/13/2026; Reply Brief due 2/27/2026; A Motion Hearing is set for 3/20/2026 at 10:00 AM in Courtroom 6D before Judge Jennifer L. Hall; Joint Status Report regarding First Trial due by 4/15/2026; Proposed Pretrial Order due by 7/20/2026; A Pretrial Conference is set for 7/27/2026 at 10:00 AM in Courtroom 6D before Judge Jennifer L. Hall; A 4-day Jury Trial is set for 8/3/2026 at 09:00 AM in Courtroom 6D before Judge Jennifer L. Hall; See Order for complete details). Signed by Judge Jennifer L. Hall on 5/6/2025. Associated Cases: 1:23-cv-00153-JLH, 1:24-cv-01344-JLH(ceg) Modified on 5/6/2025 (ceg). (Entered: 05/06/2025) (4) |
| May 6, 2025 | N/A | Case associated with lead case: Create association to 1:23-cv-00153-JLH. ALL FUTURE FILINGS SHALL BE MADE IN LEAD CASE NO. 1:23-cv-153-JLH ONLY. (ceg) (Entered: 05/06/2025) (0) |
| Apr 30, 2025 | 19 | STIPULATION and [Proposed] Order to Consolidate Actions by Vanda Pharmaceuticals Inc.. (Joyce, Alexandra) (Entered: 04/30/2025) (4) |
| Apr 24, 2025 | 18 | STIPULATION TO EXTEND TIME the deadline for the parties to submit (i) a proposed Scheduling Order; and (ii) a joint letter setting forth (a) a description of the case; (b) the parties' positions regarding any disputes in the proposed Scheduling Order; and (c) a list of any other issues the parties want to address at the Rule 16 Scheduling Conference to April 30, 2025 - filed by Vanda Pharmaceuticals Inc.. (Joyce, Alexandra) (Entered: 04/24/2025) (2) |
| Apr 24, 2025 | N/A | SO ORDERED, re 18 Stipulation and Order to Extend the Deadline for the parties to submit a Proposed Scheduling Order and a joint letter to April 30, 2025. Ordered by Judge Jennifer L. Hall on 4/24/2025. (ceg) (Entered: 04/24/2025) (0) |
| Apr 16, 2025 | 17 | STIPULATION TO EXTEND TIME the deadline for the parties to submit (i) a proposed Scheduling Order; and (ii) a joint letter setting forth (a) a description of the case; (b) the parties positions regarding any disputes in the proposed Scheduling Order; and (c) a list of any other issues the parties want to address at the Rule 16 Scheduling Conference to April 24, 2025 - filed by Vanda Pharmaceuticals Inc.. (Silver, Daniel) (Entered: 04/16/2025) (2) |
| Apr 16, 2025 | N/A | SO ORDERED, re 17 Stipulation and Order to Extend the deadline for the parties to submit a Proposed Scheduling Order and joint letter to April 24, 2025. Ordered by Judge Jennifer L. Hall on 4/16/2025. (ceg) (Entered: 04/16/2025) (0) |
| Apr 7, 2025 | 16 | ANSWER to 11 Answer to Amended Complaint, Counterclaim by Vanda Pharmaceuticals Inc..(Silver, Daniel) (Entered: 04/07/2025) (12) |
| Mar 25, 2025 | N/A | Pro Hac Vice Attorney Samoneh Kadivar Schickel for Vanda Pharmaceuticals Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. Associated Cases: 1:24-cv-01344-JLH, 1:24-cv-01345-JLH(cdd) (Entered: 03/25/2025) (0) |
| Mar 25, 2025 | N/A | Pro Hac Vice Attorney Paul W. Hughes, Jason A. Leonard for Vanda Pharmaceuticals Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. Associated Cases: 1:24-cv-01344-JLH, 1:24-cv-01345-JLH(cdd) (Entered: 03/25/2025) (0) |
| Mar 25, 2025 | N/A | Pro Hac Vice Attorney Sarah P. Hogarth, Paul W. Hughes, Mary H. Schnoor for Vanda Pharmaceuticals Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. Associated Cases: 1:24-cv-01344-JLH, 1:24-cv-01345-JLH(cdd) (Entered: 03/25/2025) (0) |
| Mar 24, 2025 | 13 | MOTION for Pro Hac Vice Appearance of Attorney Paul W. Hughes, Sarah P. Hogarth, Jason Leonard, Mary Schnoor, Samoneh Kadivar Schickel, and Connor Romm - filed by Vanda Pharmaceuticals Inc.. (Attachments: # 1 Certifications for Paul W. Hughes, Sarah P. Hogarth, Jason Leonard, Mary Schnoor, Samoneh Kadivar Schickel, and Connor Romm)(Silver, Daniel) (Entered: 03/24/2025) (0) |
| Mar 24, 2025 | 14 | Pro Hac Vice Fee - Credit Card Payment received for Paul W. Hughes, Sarah P. Hogarth, Jason Leonard, Mary Schnoor, and Samoneh Kadivar Schickel. ( re 13 MOTION for Pro Hac Vice Appearance of Attorney Paul W. Hughes, Sarah P. Hogarth, Jason Leonard, Mary Schnoor, Samoneh Kadivar Schickel, and Connor Romm )( Payment of $ 250, receipt number ADEDC-4644143).(Silver, Daniel) (Entered: 03/24/2025) (0) |
| Mar 24, 2025 | 15 | Pro Hac Vice Fee - Credit Card Payment received for Connor Romm. ( re 13 MOTION for Pro Hac Vice Appearance of Attorney Paul W. Hughes, Sarah P. Hogarth, Jason Leonard, Mary Schnoor, Samoneh Kadivar Schickel, and Connor Romm )( Payment of $ 50, receipt number ADEDC-4644147).(Silver, Daniel) (Entered: 03/24/2025) (0) |
| Mar 24, 2025 | N/A | SO ORDERED, re (13 in 1:24-cv-01344-JLH, 14 in 1:24-cv-01345-JLH) Motion for Pro Hac Vice Appearance of Attorney Paul W. Hughes, Sarah P. Hogarth, Jason Leonard, Mary Schnoor, Samoneh Kadivar Schickel, and Connor Romm filed by Vanda Pharmaceuticals Inc. Ordered by Judge Jennifer L. Hall on 3/24/2025. Associated Cases: 1:24-cv-01344-JLH, 1:24-cv-01345-JLH(ceg) (Entered: 03/24/2025) (0) |
| Mar 18, 2025 | 12 | ORAL ORDER: IT IS HEREBY ORDERED that, within thirty days, the parties shall jointly prepare and file the following: (i) a proposed Scheduling Order consistent with Judge Hall's "Rule 16 Scheduling Order - Patent", and (ii) a letter, not to exceed three pages, setting forth (a) a description of what this case is about; (b) the parties' positions regarding any disputes in the proposed Scheduling Order; and (c) a list of any other issues the parties want to address at the Rule 16 Scheduling Conference. Thereafter, the Court may schedule a Rule 16 Scheduling Conference to be held with Judge Hall. The Scheduling Order can be found on Judge Hall's portion of the District Court's website. Ordered by Judge Jennifer L. Hall on 3/18/2025. (ceg) (Entered: 03/18/2025) (0) |
| Mar 17, 2025 | 11 | ANSWER to 6 Amended Complaint, COUNTERCLAIM against Vanda Pharmaceuticals Inc. by Apotex Corp., Apotex Inc.(Ekiner, Kaan) Modified on 3/18/2025 (ceg). (Entered: 03/17/2025) (30) |
| Mar 5, 2025 | 10 | DECLARATION of Daniel M. Silver regarding Service for Apotex Inc. by Federal Express on January 27, 2025, by Vanda Pharmaceuticals Inc.. (Attachments: # 1 Exhibit A-B)(Silver, Daniel) Modified on 3/5/2025 (ceg). (Entered: 03/05/2025) (0) |
| Feb 13, 2025 | N/A | SO ORDERED, re 8 Stipulation and Order to Extend Time for Defendants to move, plead, or otherwise respond to Plaintiff's First Amended Complaint to March 17, 2025. (*Reset Answer Deadlines: Apotex Corp. answer due 3/17/2025; Apotex Inc. answer due 3/17/2025). Ordered by Judge Jennifer L. Hall on 2/13/2025. (ceg) (Entered: 02/13/2025) (0) |
| Feb 12, 2025 | 8 | STIPULATION TO EXTEND TIME for Defendants to move, plead, or otherwise respond to Plaintiff's First Amended Complaint to March 17, 2025 - filed by Apotex Corp., Apotex Inc.. (Ekiner, Kaan) (Entered: 02/12/2025) (1) |
| Feb 12, 2025 | 9 | Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Aposherm Delaware Holdings Corp. for Apotex Corp.; Corporate Parent Apotex Holdco Inc. for Apotex Inc. filed by Apotex Corp., Apotex Inc.. (Ekiner, Kaan) (Entered: 02/12/2025) (1) |
| Jan 24, 2025 | 7 | SUMMONS Returned Executed by Vanda Pharmaceuticals Inc..Apotex Corp. served on 1/24/2025, answer due 2/14/2025. (Joyce, Alexandra) (Entered: 01/24/2025) (2) |
| Jan 23, 2025 | 6 | Amended Complaint* (1) |
| Dec 11, 2024 | N/A | Case Assigned to Judge Jennifer L. Hall. Please include the initials of the Judge (JLH) after the case number on all documents filed. Associated Cases: 1:24-cv-01344-JLH, 1:24-cv-01345-JLH (rjb) (Entered: 12/11/2024) (0) |
| Dec 9, 2024 | 1 | Complaint* (1) |
| Dec 9, 2024 | 2 | Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (oam) (Entered: 12/10/2024) (3) |
| Dec 9, 2024 | 3 | Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 11,918,556. (oam) (Entered: 12/10/2024) (1) |
| Dec 9, 2024 | 4 | Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Black Rock Fund Advisors for Vanda Pharmaceuticals Inc. filed by Vanda Pharmaceuticals Inc. (oam) (Entered: 12/10/2024) (1) |
| Dec 9, 2024 | 5 | Summons Issued as to Apotex Corp., Apotex Inc.. (Attachments: # 1 Summons Issued)(oam) (Entered: 12/10/2024) (0) |
